{
  "context": {
    "rules": [
      "Rule1: If drug delivery requires cold storage, then drug delivery requires secure transport.",
      "Rule2: Either drug delivery requires cold storage, or drug distribution is regulated.",
      "Rule3: Whenever the drug batch is compliant with regulations, it is not the case that the drug batch is contaminated.",
      "Rule4: Under the condition that the drug batch is scheduled for lab testing, if the drug batch is inspected by an FDA agent, then the drug batch is compliant with regulations.",
      "Rule5: Either the drug batch is scheduled for lab testing, or the drug batch is scheduled for field testing.",
      "Rule6: Provided that the drug batch is scheduled for field testing, whenever the drug batch is inspected by an FDA agent, it follows that the drug batch is compliant with regulations.",
      "Rule7: Either the distribution center utilizes a refrigerated truck, or it utilizes an armored truck.",
      "Rule8: Given that the distribution center utilizes an armored truck, drug distribution is regulated.",
      "Rule9: Should the refrigerated truck be damaged, the refrigeration unit is malfunctioning.",
      "Rule10: Whenever drug delivery requires secure transport, it also requires a licensed driver.",
      "Rule11: If the FDA monitors the drug shipment, then either the drug shipment is rerouted, or under the condition that drug distribution is not regulated, the drug shipment is expedited.",
      "Rule12: If the FDA approves the drug formula, then the FDA does not penalize the pharmaceutical company.",
      "Rule13: If the appeal is filed by the pharmaceutical company, then if it is not the case that whenever the pharmaceutical company is registered with the FDA, drug distribution is regulated, leading to the pharmaceutical license not being suspended, then the pharmaceutical license is reinstated.",
      "Rule14: Provided that the appeal is filed by the pharmaceutical lawyer, if it is not the case that whenever the pharmaceutical company is registered with the FDA, drug distribution is regulated, which implies that the pharmaceutical license is not suspended, then the pharmaceutical license is reinstated.",
      "Rule15: If the appeal is reviewed by the regulatory board, then either the appeal is filed by the pharmaceutical company, or it is filed by the pharmaceutical lawyer.",
      "Rule16: Under the condition that the appeal is assigned to a senior inspector, the appeal is reviewed by the regulatory board.",
      "Rule17: Either the appeal is assigned to a senior inspector, or it is assigned to a legal team.",
      "Rule18: If the appeal is assigned to a legal team, then the appeal is reviewed by the regulatory board.",
      "Rule19: If the pharmaceutical company violates storage guidelines, then drug delivery does not require secure transport.",
      "Rule20: Either the temperature breach is detected by quality control, or it is detected by the distribution manager.",
      "Rule21: In the event that the temperature breach is detected by the distribution manager, then if it is not the case that the distribution center utilizing a refrigerated truck implies drug distribution is regulated, the drug shipment is delayed.",
      "Rule22: If the temperature breach is logged in the system, then should it not be the case that the distribution center utilizing a refrigerated truck implies drug distribution is regulated, the drug shipment is delayed.",
      "Rule23: If the pharmaceutical company possesses an export license, then drug delivery does not require a licensed driver.",
      "Rule24: Under the condition that the pharmaceutical company is under investigation, the pharmaceutical license is not suspended.",
      "Rule25: If the pharmaceutical company is audited, then it is under investigation.",
      "Rule26: In the event that the compliance report is accepted by the FDA, then if the compliance report is submitted by the pharmaceutical company, and if it is not the case that the pharmaceutical company being registered with the FDA implies drug distribution is regulated, then the pharmaceutical company is audited.",
      "Rule27: Provided that the compliance report is rejected by the FDA, then if the compliance report is submitted by the pharmaceutical company, and if it is not the case that the pharmaceutical company being registered with the FDA implies drug distribution is regulated, then the pharmaceutical company is audited.",
      "Rule28: If the compliance report is forwarded to the review committee, then either it is accepted by the FDA, or it is rejected by the FDA.",
      "Rule29: Either the compliance report is forwarded to the review committee, or it is returned to the pharmaceutical company.",
      "Rule30: Whenever the compliance report is returned to the pharmaceutical company, it is either accepted by the FDA or rejected by the FDA.",
      "Rule31: Either the appeal is processed within the deadline, or if the appeal is acknowledged by the regulatory board, then it is filed by the pharmaceutical company or by the pharmaceutical lawyer.",
      "Rule32: If the appeal requires a legal hearing, then the legal hearing is scheduled.",
      "Rule33: Either the appeal requires a legal hearing, or it is not the case that the appeal is processed within the deadline.",
      "Rule34: Provided that corrective actions are provided by the pharmaceutical company, then if it is not the case that the pharmaceutical company being registered with the FDA implies drug distribution is regulated, the pharmaceutical license is not suspended.",
      "Rule35: Either corrective actions are provided by the pharmaceutical company, or they are provided by the consultant.",
      "Rule36: If corrective actions are verified by the FDA, then whenever they are provided by the consultant, and if it is not the case that the pharmaceutical company being registered with the FDA implies drug distribution is regulated, the pharmaceutical license is not suspended.",
      "Rule37: Either the compliance audit is initiated by the FDA, or it is initiated by the health ministry.",
      "Rule38: Under the condition that the compliance audit is initiated by the health ministry, then if it is not the case that the negation of the implication that the pharmaceutical company being registered with the FDA implies drug distribution is regulated, leading to the pharmaceutical license not being suspended, which then leads to the pharmaceutical license being reinstated, and if the compliance audit is completed, then the pharmaceutical company is not cleared.",
      "Rule39: If the compliance audit is supervised by a senior officer, then either it involves a document review, or it involves a field inspection, or if the compliance audit is initiated by the FDA, then if it is not the case that the negation of the implication that the pharmaceutical company being registered with the FDA implies drug distribution is regulated, leading to the pharmaceutical license not being suspended, which then leads to the pharmaceutical license being reinstated, and if the compliance audit is completed, then the pharmaceutical company is not cleared.",
      "Rule40: Either the drug batch is contaminated, or if it is not the case that drug distribution not being regulated implies the drug shipment is not approved by the FDA, then the drug shipment does not pass the quality check.",
      "Rule41: Either the drug batch is inspected by an FDA agent, or it is inspected by a customs agent.",
      "Rule42: Should the drug batch be inspected by a customs agent, then it is not contaminated.",
      "Rule43: Under the condition that it is not the case that the distribution center utilizing a refrigerated truck implies drug distribution is regulated, the refrigerated truck is damaged.",
      "Rule44: If it is not the case that the refrigeration unit malfunctioning implies the drug shipment is delayed, then the drug shipment is diverted.",
      "Rule45: In the event that it is not the case that the pharmaceutical company being registered with the FDA implies drug distribution is regulated, the pharmaceutical license is suspended.",
      "Rule46: Whenever it is not the case that the pharmaceutical company violating safety protocols implies it violates storage guidelines, the pharmaceutical company is fined.",
      "Rule47: In the event that it is not the case that the pharmaceutical company violating safety protocols implies it violates storage guidelines, the pharmaceutical company is not fined.",
      "Rule48: Should it not be the case that the temperature breach being detected by quality control implies it is logged in the system, the emergency shipment is authorized by the pharmaceutical director.",
      "Rule49: Provided that it is not the case that the emergency shipment being authorized by the pharmaceutical director implies it is approved by the medical board, the emergency shipment is not dispatched.",
      "Rule50: If it is not the case that the health ministry overseeing drug distribution implies either the emergency shipment is coordinated with the hospital or if it is not the case that the emergency shipment being authorized by the pharmaceutical director implies it is approved by the medical board, then the emergency shipment is dispatched, then the health ministry intervenes in the distribution process.",
      "Rule51: Should it not be the case that the health ministry overseeing drug distribution implies either the emergency shipment is coordinated with the hospital or if it is not the case that the emergency shipment being authorized by the pharmaceutical director implies it is approved by the medical board, then the emergency shipment is dispatched, then the health ministry does not intervene in the distribution process.",
      "Rule52: In the event that it is not the case that the negation of the implication that the pharmaceutical company being registered with the FDA implies drug distribution is regulated, leading to the pharmaceutical license not being suspended, then the pharmaceutical license is not reinstated.",
      "Rule53: Under the condition that it is not the case that the negation of the implication that the pharmaceutical company being registered with the FDA implies drug distribution is regulated, leading to the pharmaceutical license not being suspended, which then leads to the pharmaceutical license being reinstated, then the compliance audit is not completed.",
      "Rule54: Should it not be the case that the negation of the implication that the pharmaceutical company being registered with the FDA implies drug distribution is regulated, leading to the pharmaceutical license not being suspended, which then leads to the pharmaceutical license being reinstated, and if the compliance audit is completed, then the pharmaceutical company is cleared.",
      "Rule55: In the event that it is not the case that the FDA not monitoring the drug shipment implies it investigates the pharmaceutical company, then the FDA penalizes the pharmaceutical company.",
      "Rule56: Provided that it is not the case that drug distribution not being regulated implies the drug shipment is not approved by the FDA, then the drug shipment passes the quality check.",
      "Rule57: Should the FDA not monitor the drug shipment, then it does not investigate the pharmaceutical company.",
      "Rule58: Provided that drug distribution is not regulated, the drug shipment is approved by the FDA."
    ],
    "facts": [
      "Fact1: The FDA approves the drug formula.",
      "Fact2: The pharmaceutical company is registered with the FDA.",
      "Fact3: The pharmaceutical company violates safety protocols.",
      "Fact4: The pharmaceutical company possesses an export license.",
      "Fact5: The health ministry oversees drug distribution.",
      "Fact6: The compliance report is submitted by the pharmaceutical company.",
      "Fact7: The appeal is acknowledged by the regulatory board.",
      "Fact8: Corrective actions are verified by the FDA.",
      "Fact9: The compliance audit is supervised by a senior officer.",
      "Fact10: The drug shipment is not delayed.",
      "Fact11: The drug shipment is not diverted.",
      "Fact12: The drug shipment is not expedited.",
      "Fact13: The drug shipment is not rerouted.",
      "Fact14: The emergency shipment is not approved by the medical board.",
      "Fact15: The emergency shipment is not coordinated with the hospital.",
      "Fact16: The legal hearing is not scheduled.",
      "Fact17: It is not the case that the compliance audit involves a field inspection.",
      "Fact18: It is not the case that the compliance audit involves a document review."
    ]
  },
  "question": "Drug distribution is regulated."
}